Get startedLog in
    Picture of Shandong Weigao Medical Polymer Co logo

    1066 — Shandong Weigao Medical Polymer Co Income Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Shandong Weigao Medical Polymer Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    R2020
    December 31st
    R2021
    December 31st
    R2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue11,62213,20913,74713,22913,087
    Cost of Revenue
    Gross Profit6,4897,3467,2936,6116,536
    Selling / General / Administrative Expenses
    Research And Development
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses8,88710,26010,24510,66410,359
    Operating Profit2,7352,9493,5022,5652,729
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes2,5652,8783,3862,3692,554
    Provision for Income Taxes
    Net Income After Taxes2,2072,4582,9502,0622,163
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income2,0872,2762,7642,0022,067
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Dilution Adjustment
    Diluted Net Income2,0872,2752,7632,0022,067
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.4680.5480.6220.440.453
    Dividends per Share